Anti-obesity Medication Market Analysis 2024-2034 by Product, Mechanism of Action, Distribution Channel and Region - Global Industry Projected to Register 31.71% CAGR, Reaching $137.4 Billion by 2034
26 juin 2024 06h55 HE
|
Research and Markets
Dublin, June 26, 2024 (GLOBE NEWSWIRE) -- The "Global Anti-obesity Medication Market" report has been added to ResearchAndMarkets.com's offering.The global anti-obesity medication market accounted...
Global Anti-obesity Medication Market Trends Analysis Report 2024-2030: Social Media Influences and Strategic Partnerships, Mergers, Acquisitions, and Collaborations Shaping the Landscape
11 avr. 2024 11h14 HE
|
Research and Markets
Dublin, April 11, 2024 (GLOBE NEWSWIRE) -- The "Global Anti-obesity Medication Market Size, Share & Trends Analysis Report" report has been added to ResearchAndMarkets.com's offering.The global...
Anti-Obesity Drug Market to Witness Robust Growth Through 2028 Amid Rising Global Obesity Concerns
20 déc. 2023 10h38 HE
|
Research and Markets
Dublin, Dec. 20, 2023 (GLOBE NEWSWIRE) -- The "Anti-obesity Drug Market Forecasts from 2023 to 2028" report has been added to ResearchAndMarkets.com's offering.The anti-obesity drug market is...
PFX Labs Release The Best Legal Phentermine Alternatives Chosen By Outlook India in 2022
11 août 2022 09h00 HE
|
PFX Labs
Kington, Aug. 11, 2022 (GLOBE NEWSWIRE) -- PFX Labs impressive phentermine alternative ShredCBD won the vote by Outlook India as the best over the counter fat burning and weight loss solution with...
Medical Weight Loss and Beauty Helps Californians Lose Weight and Feel Confident in Their Own Skin
13 avr. 2022 09h00 HE
|
Medical Weight Loss and Beauty
Pasadena, April 13, 2022 (GLOBE NEWSWIRE) -- There are many different reasons for wanting to lose weight and look your best, from feeling confident in your own skin to wanting to get healthier and...
Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2013, FQ4/13 Revenues Highest in Corporate History
21 juin 2013 13h44 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., June 21, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral abuse-resistant...
Elite Pharmaceuticals, Inc. Announces 2013 Fiscal Year End Conference Call on Monday, June 24, 2013
19 juin 2013 08h00 HE
|
Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., June 19, 2013 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. (OTCBB:ELTP), a specialty pharmaceutical company dedicated to developing and commercializing oral sustained and...